NS · Pharmaceuticals
Pharmaceuticals & Biotechnology
Kilitch Drugs (India) Ltd (KILITCH) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-11, reported market cap is $6.75B, P/E ratio is 20.77, net margin is 14.9%, dividend yield is 0.26%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Kilitch Drugs (India) Ltd (KILITCH) has a reported market cap of $6.75B (data as of 2026-07-11).
The price-to-earnings (P/E) ratio for Kilitch Drugs (India) Ltd (KILITCH) is 20.77 (data as of 2026-07-11).
Kilitch Drugs (India) Ltd (KILITCH) shows a reported dividend yield of 0.26%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-11).
Kilitch Drugs (India) Ltd (KILITCH) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
KILITCH is listed on NS.
Kilitch Drugs (India) Ltd (KILITCH) reports a net margin of 14.9% (data as of 2026-07-11).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.